Sanctuary Advisors’s Transmedics TMDX Stock Holding History

Sanctuary Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,694	Closed	-$206K	–	2630
2025 Q4	$206K	Buy	+1,694	New	+$213K	﹤0.01%	2268
2025 Q3	–	Sell	-3,103	Closed	-$416K	–	2544
2025 Q2	$416K	Buy	+3,103	New	+$341K	﹤0.01%	1721
2024 Q4	–	Sell	-4,041	Closed	-$307K	–	2498
2024 Q3	$307K	Buy	4,041 +1,568	+63%	+$242K	﹤0.01%	1974
2024 Q2	$228K	Buy	+2,473	New	+$297K	﹤0.01%	2102

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanctuary Advisors's TMDX Position: Q1 2026 in Review

Sanctuary Advisors sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 1,694 shares — an estimated $206K sold.

Sanctuary Advisors first reported a position in TMDX in Q2 2024 and held it in 4 quarters. The position peaked at $416K in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Sanctuary Advisors reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
Sanctuary Advisors sold 1,694 Transmedics shares in Q1 2026, an estimated $206K.
Sanctuary Advisors first reported a position in Transmedics in Q2 2024 and held it in 4 quarters.
Sanctuary Advisors's Transmedics position peaked at $416K in Q2 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.